Seeking Alpha

AMAG Pharmaceuticals Inc. (AMAG)

()

News & PR
Market Currents

Buzz
Twitter: AMAG

Business Intelligence
Transcripts
Events
Key Developments

Analysis - Latest Articles by most recent | most commented

Goldman Sachs Hedge Fund Trend Monitor

Sep 4 • Mebane Faber • 2 Comments
Rockwell Medical's Potential for Exponential Gains

Sep 2 • Mike Havrilla • Comment!
AMAG Pharmaceuticals' Feraheme: The Next Billion Dollar Drug

Aug 3 • Nikos Celletia • 1 Comment
Biotech ETFs Surge Again on M&A News

Jul 24 • Michael Johnston • Comment!
Closing Update for Wednesday, July 1

Jul 1 • Midnight Trader • 1 Comment
Wednesday's Options Recap

Jul 1 • Frederic Ruffy • 1 Comment
FDA Calendar Updates: AspenBio, CytRx, Cephalon, Pozen, Sanofi, AMAG

Jul 1 • Mike Havrilla • 2 Comments
FDA Calendar Updates: AMAG Pharma, Takeda

Jun 30 • Mike Havrilla • 1 Comment
AMAG Pharmaceuticals: Straddle Options Position Not for the Faint of Heart

Jun 28 • The Inflection Point • 2 Comments
Expect FDA Approval of AMAG Pharmaceutical's Feraheme

Jun 26 • Kaushik Paul • 16 Comments
FDA Calendar: 18 Hot Summer Trades

Jun 16 • Mike Havrilla • 4 Comments
Galleon Bets Heavily on the S&P 500

Jun 9 • Market Folly • Comment!
Biotech Opportunities: Look for Decent Pipeline, Big Pharma Partnerships

Jun 2 • Zacks.com • 15 Comments
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly

May 27 • Mark Cifra • 4 Comments
AMAG Pharma: Strong Prospects for Feraheme's Success

May 26 • The Inflection Point • 2 Comments
3S Bio: Post-Earnings, Still a Buy

May 21 • Zacks.com • Comment!
FDA, Clinical Trial Calendar Updates: AMAG Pharma, Immunomedics

May 13 • Mike Havrilla • Comment!
FDA Calendar Updates: AMAG Pharma Up, Northfield Labs Down

May 1 • Mike Havrilla • Comment!
Sequenom's Bombshell

Apr 30 • TraderMark • 13 Comments
Galleon's Q408: SPY Pays Off Alongside Reduced Equity Positions

Apr 21 • Market Folly • Comment!
Where Might Genentech Investors Redeploy $47B?

Mar 16 • Michael Becker • 2 Comments
Three Oversold Healthcare Catalyst Stocks

Mar 12 • Mike Havrilla • Comment!
Know Your Options When Investing in Biotech Stocks

Mar 2 • Zacks.com • 5 Comments
Create Your Own Diagnostics ETF

Jan 21 • Mike Havrilla • 3 Comments
Hedge Fund Portfolio Tracking: Galleon Group (Raj Rajaratnam), Q3 2008

Jan 16 • Market Folly • 1 Comment
Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys

Jan 15 • Mike Havrilla • 4 Comments
20 Emerging Healthcare Stocks to Watch in '09

Jan 11 • Mike Havrilla • 4 Comments
Trading FDA Decisions: AMAG Looks Like a Buy

Jan 9 • Mike Havrilla • Comment!
Tuesday Options Update: EBAY, SBUX, GE & AMAG

Dec 23, 2008 • Andrew Wilkinson • 2 Comments
Five Healthcare Stocks Positioned for a Happy New Year

Dec 23, 2008 • Mike Havrilla • 1 Comment
FDA Calendar Update: High Hopes for Amgen's Bone Drug

Dec 21, 2008 • Mike Havrilla • Comment!
AMAG, Caraco and More: Near-Term Catalysts, Courtesy FDA

Dec 3, 2008 • Mike Havrilla • Comment!
Full FDA Calendar for Remainder 2008

Nov 14, 2008 • Mike Havrilla • Comment!
Monday Options Update: AMAG, XME, THOR, MSFT, SLXP, CEG, ING, RIMM

Oct 20, 2008 • Andrew Wilkinson • 2 Comments
Biotech Outlook: M&A Will Continue

Sep 2, 2008 • Zacks.com • 2 Comments
AMAG's Iron Replacement Therapy: Great Potential, Problematic Trial

Jul 1, 2008 • A. Reza Saadat • 2 Comments
AMAG Pharma Should Jump on Jefferies Note

Jun 2, 2008 • Notable Calls • 1 Comment
AMAG Pharma, 3SBio Partner to Develop Ferumoxytol Market in China

May 29, 2008 • Interfax-China • 1 Comment
AMAG Pharma: What's Taking the FDA So Long?

Apr 17, 2008 • Dan Rosenblum • 1 Comment
Jeffries Out Bullish on Amag Pharma

Apr 10, 2008 • Notable Calls • Comment!
AMAG Pharmaceuticals Worth Far Less - Merrill

Apr 9, 2008 • Notable Calls • 1 Comment

AMAG Pharmaceuticals Inc. (AMAG)

Analysis - Latest Articles by most recent | most commented

The Seeking Alpha 100

Fastest Climbers

Top Commenters

Top Instabloggers

Top StockTalkers